1-Linoleoyl Glycerol

CAS No. 2277-28-3

1-Linoleoyl Glycerol( 1-Linoleoyl-rac-glycerol | Glyceryl monolinoleate | Monolinolein | Glycerol 1-monolinolate )

Catalog No. M26010 CAS No. 2277-28-3

1-Linoleoyl Glycerol is fatty acid glycerol that has been isolated from Saururus Chinensis roots.

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
1 mL x 10 mM in DMSO 52 In Stock
25MG 28 In Stock
100MG Get Quote In Stock
200MG Get Quote In Stock
500MG Get Quote In Stock
1G Get Quote In Stock

Biological Information

  • Product Name
    1-Linoleoyl Glycerol
  • Note
    Research use only, not for human use.
  • Brief Description
    1-Linoleoyl Glycerol is fatty acid glycerol that has been isolated from Saururus Chinensis roots.
  • Description
    1-Linoleoyl Glycerol is fatty acid glycerol that has been isolated from Saururus Chinensis roots. The (R)-1-Linoleoyl Glycerol and (S)-1-Linoleoyl Glycerol exhibit Lipoprotein-associated phospholipase A2 (Lp-PLA2) inhibitory activities with IC50 values of 45.0 and 52.0 μM, respectively.
  • In Vitro
    ——
  • In Vivo
    ——
  • Synonyms
    1-Linoleoyl-rac-glycerol | Glyceryl monolinoleate | Monolinolein | Glycerol 1-monolinolate
  • Pathway
    Metabolic Enzyme/Protease
  • Target
    Phospholipase
  • Recptor
    ——
  • Research Area
    ——
  • Indication
    ——

Chemical Information

  • CAS Number
    2277-28-3
  • Formula Weight
    354.531
  • Molecular Formula
    C21H38O4
  • Purity
    >98% (HPLC)
  • Solubility
    In Vitro:?DMSO : ≥ 100 mg/mL (282.07 mM)
  • SMILES
    CCCCC\C=C/C\C=C/CCCCCCCC(=O)OCC(O)CO
  • Chemical Name
    ——

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

1.Fujino H, et al. Metabolic fate of pitavastatin, a new inhibitor of HMG-CoA reductase: human UDP-glucuronosyltransferase enzymes involved in lactonization. Xenobiotica. 2003 Jan;33(1):27-41.
molnova catalog
related products
  • Giripladib

    Giripladib (PLA695)(PLX-695) is a cPLA2-specific inhibitor that inhibits the radiation-induced increase of phosphorylated ERK and phosphorylated Akt in endothelial cells.

  • VU0359595

    VU0359595 (ML-270) is a potent and selective pharmacological phospholipase D1 (PLD1) inhibitor with an IC50 of 3.7 nM. VU0359595 is >1700-fold selective for PLD1 over PLD2 (IC50 of 6.4 μM).

  • Lp-PLA2-IN-3

    Lp-PLA2-IN-3 is a potent, orally bioactive lipoprotein-associated phospholipase A2 (Lp-PLA2) inhibitor, effectively inhibiting recombinant human [Lp-PLA2] with an IC50 value of 14 nM.